SCHEDULE 13G: Kynam Capital Management Discloses 9.8% Stake in enGene Holdings Inc.

Kynam Capital Management, LP, along with its general partner and managing member, has reported a collective beneficial ownership of 9.8% of enGene Holdings Inc.'s common shares.

Summary

• Kynam Capital Management, LP, Kynam Capital Management GP, LLC, and Yue Tang collectively reported beneficial ownership of 4,994,090 common shares of enGene Holdings Inc.
• This ownership represents 9.8% of the total class of enGene Holdings Inc.'s common shares.
• The shares are held with shared voting power and shared dispositive power among the reporting persons.
• The filing indicates that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: Neutral, as this filing is a standard disclosure of beneficial ownership and does not contain performance or operational updates, nor does it indicate any intent to influence control.

Future Outlook

NA

Industry Context

This filing is a standard disclosure of significant passive ownership by an investment entity in a publicly traded company, common across various industries as part of regulatory transparency requirements.

Stakeholder Impact

• Shareholders: Disclosure of a significant institutional holder (9.8%) may provide a sense of stability or validation for the company's stock.

Key Dates

Keywords

enGene Holdings Inc., Kynam Capital Management, Beneficial Ownership, Schedule 13G, SEC Filing, Common Shares, Investment Adviser, Institutional Ownership